...was first to share https://www.iqvia.com/en/blogs/2021/06/midas-sales-by-disease-insight-series-4 in this tweet:

Breast cancer treatment pioneered some of the earliest targeted biologics in #oncology, and since then, therapy options have increased significantly. This #BreastCancerAwarenessMonth, take a closer look at the advancements in breast cancer treatments: https://bit.ly/3jcMl88 https://t.co/zEPKPglPpy

2021-10-18 11:00:07 UTC

 Share the link yourself with

...was first to share https://www.businesswire.com/news/home/20211015005140/en in this tweet:

PIK3CA multiplex #dPCR assay covering 24 mutations and LoD < 0.01 MAF? No problem for SAGA's chemistry on Stilla's new system. #precisionmedicine #precisiondiagnostics #oncology #cancer #brca

2021-10-18 11:10:01 UTC

 Share the link yourself with

...was first to share https://www.fiercebiotech.com/medtech/roche-pathai-digital-pathology-cancer-artificial-intelligence in this tweet:

Roche welcomes PathAI into its open digital pathology initiative! The coordinated effort to start with PathAI’s algorithms for research use only, spanning multiple types of cancer! $RHHBY #AI #oncology #research #AI https://bit.ly/3n1Qxcd

2021-10-18 11:25:00 UTC

 Share the link yourself with

...was first to share https://peerj.com/articles/12276/ in this tweet:

Identification and validation of a novel zinc finger protein-related gene-based prognostic model for #breast #cancer Read the full article https://bit.ly/3E67R6P #Bioinformatics #Oncology #breastcancer https://t.co/XgRYYYgSth

2021-10-18 14:30:09 UTC

 Share the link yourself with

...was first to share https://congress.maurizionava.it/ in this tweet:

A special invitation from Dr. Lan Mu. #MBN2021 Registration and more info here: https://congress.maurizionava.it/ Thank you. #MaurizioNava #NeverStopLearning #NSLTV #Oncology #OncologyResearch #Surgery #Milano https://t.co/TJ2PZWKoz5

2021-10-18 15:27:50 UTC

 Share the link yourself with

...was first to share https://www.eatrightstore.org/ in this tweet:

Shop for the latest new releases in the #FNCE eatrightSTORE, including the long-awaited second edition of "#Oncology Nutrition for Clinical Practice" and the brand new "Health Professional’s Guide to Nutrition, #Diabetes, and Pregnancy." 📚 https://sm.eatright.org/eatrightSTORE #eatrightPRO https://t.co/KxRCmFicE9

2021-10-18 16:51:06 UTC

 Share the link yourself with

...was first to share https://ascopost.com/news/october-2021/characteristics-of-genomically-targeted-single-patient-use-requests-for-pediatric-cancers/ in this tweet:

Characteristics of Genomically Targeted Single-Patient Use Requests for Pediatric Cancers https://ascopost.com/news/october-2021/characteristics-of-genomically-targeted-single-patient-use-requests-for-pediatric-cancers/ #pedonc #oncology #cancer #genomics

2021-10-18 18:38:00 UTC

 Share the link yourself with

...was first to share https://documentcloud.adobe.com/link/review in this tweet:

🏆[#PrixGalienMedstartup] Next week, meet 🇫🇷companies and discover their cutting-edge solutions in #oncology, #neurology, #cardiology and age-related diseases. To learn more about the French delegation 👉https://adobe.ly/30y4Q0l @GalienFdn @FrHealthCare_EN @BF_NorthAmerica https://t.co/bba1LgA9NQ

2021-10-18 20:40:53 UTC

 Share the link yourself with

...was first to share https://www.frontiersin.org/articles/10.3389/fonc.2021.762528/full in this tweet:

New research: FGFR4 Gly388Arg Polymorphism Reveals a Poor Prognosis, Especially in Asian Cancer Patients: A Meta-Analysis: The fibroblast growth factor-4 receptor (FGFR4) is a member of receptor tyrosine kinase. The FGFR4 Gly388Arg polymorphism… https://www.frontiersin.org/articles/10.3389/fonc.2021.762528?utm_source=S-TWT&utm_medium=SNET&utm_campaign=ECO_FONC_XXXXXXXX_auto-dlvrit #oncology

2021-10-19 05:20:32 UTC

 Share the link yourself with

...was first to share https://ascopost.com/news/october-2021/fda-perspective-on-drug-dosing-in-oncology-from-more-is-better-to-less-can-be-more/ in this tweet:

.@US_FDA Perspective on Drug-Dosing in Oncology: From ‘More Is Better’ to ‘Less Can Be More’ https://ascopost.com/news/october-2021/fda-perspective-on-drug-dosing-in-oncology-from-more-is-better-to-less-can-be-more/ @FDAOncology #oncology

2021-10-19 12:51:00 UTC

 Share the link yourself with